Test Price
2,800 AED✅ Home Collection Available
CEP41 Gene Joubert Syndrome Type 15 Genetic Test – 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Your Genomic Certainty Roadmap
- ✔ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited NGS processing, targeting the entire CEP41 coding region with deep sequencing (>100x mean coverage).
- ✔ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. DNA‑stabilised samples (whole blood or FTA card) transported in compliance with ISO 9001:2015.
- ✔ Clinical Guidance: Telephonic post‑test clinical correlation session with a DHA‑certified clinical geneticist (English / Arabic).
- ✔ Insurance: Direct billing verification via WhatsApp to +971 54 548 8731. Pre‑approval letter within 2 hours.
Test Overview & Methodology
What Is the CEP41 Gene Joubert Syndrome Type 15 DNA Test?
This clinical‑grade next‑generation sequencing (NGS) test comprehensively screens the CEP41 gene for pathogenic variants linked to Joubert syndrome type 15, a rare ciliopathy characterised by cerebellar vermis hypoplasia, hypotonia, and oculomotor apraxia. Designed for symptomatic patients, at‑risk families, and researchers, the assay delivers a definitive molecular diagnosis, guiding early intervention and personalised neurological care under DHA oversight.
Our Test vs. Closest Alternative
| Feature | Our CEP41 NGS Test | Standard Single‑Gene Sequencing |
|---|---|---|
| Methodology | NGS (Illumina® HiSeq), full coding exons ±20 bp splice sites | Sanger sequencing (limited to selected exons only) |
| Analytical Sensitivity | >99.9% for single nucleotide variants and small indels | ~95% (may miss deep intronic or large rearrangements) |
| Turnaround Time | 3–4 weeks with expedited clinical report | 5–7 weeks |
| Regulatory Compliance | DHA‑licensed facility (License #1143); ISO 9001:2015 | Varies; often lacks UAE‑specific accreditation |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I emphasise that a positive CEP41 variant confirms the clinical diagnosis of Joubert syndrome type 15. However, every genetic result must be interpreted in conjunction with the patient’s full clinical picture, family history, and neuroimaging findings. Never alter treatment solely on a genetic test; always discuss findings with a multidisciplinary team. Your family’s peace of mind begins with expert post‑test counselling.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory & Medication Precautions
Do not discontinue or modify any prescribed medication without consulting your treating physician. This genetic test provides diagnostic information, not therapeutic guidance. Abrupt changes to antiepileptic or neurological drugs may provoke serious adverse events.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients unable to provide informed consent (and lacking a legally authorised representative) as per Federal Decree‑Law No. 4 of 2016 on Medical Liability and UAE federal regulations for minors.
- Red Flag: Sudden worsening of hypotonia, apnoeic episodes, or seizure clusters in an infant awaiting results – proceed immediately to the nearest emergency department.
- Red Flag: If the DNA sample is compromised (e.g., clotted blood tube), recollection will be offered at no extra charge.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the CEP41 gene test, and how accurate is it?
This test definitively identifies pathogenic mutations in the CEP41 gene causing Joubert syndrome type 15 with >99.9% diagnostic sensitivity, confirming clinical suspicion in patients and identifying carrier status in at‑risk relatives.
2. Do I need to fast or prepare in any way before the sample collection?
No special preparation is required. A simple whole blood sample (EDTA) or an FTA card buccal swab is sufficient. We recommend a pre‑test genetic counselling session to document your family history.
3. How will I receive my results and what support is provided afterwards?
Your comprehensive report is delivered within 3–4 weeks via a secure DHA‑compliant portal, followed by a complimentary tele‑consultation with a clinical geneticist who will explain variant interpretation, recurrence risk, and next steps for family planning.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Privacy Assurance
DNA Labs UAE operates under DHA Facility License No. 1143, strictly adhering to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored in‑country, and accessible only to authorised medical personnel. No data is shared with third parties without explicit patient consent.
Clinical & Logistical Metadata
| Test Name | CEP41 Gene Joubert Syndrome Type 15 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (expedited report available) |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card – also accepts extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina® HiSeq, full coding exons ±20 bp splice sites |
| ICD-10-CM Code | Q04.3 (Joubert syndrome) |
| LOINC Code | 81315-1 (CEP41 gene mutation analysis) |
| DHA Facility License & Lab Address | License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians